These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 15716584)
1. Acute inhibition of hepatic beta-oxidation in APOE*3Leiden mice does not affect hepatic VLDL secretion or insulin sensitivity. Duivenvoorden I; Teusink B; Rensen PC; Kuipers F; Romijn JA; Havekes LM; Voshol PJ J Lipid Res; 2005 May; 46(5):988-93. PubMed ID: 15716584 [TBL] [Abstract][Full Text] [Related]
2. Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1. Jong MC; Dahlmans VE; van Gorp PJ; Breuer ML; Mol MJ; van der Zee A; Frants RR; Hofker MH; Havekes LM Arterioscler Thromb Vasc Biol; 1996 Aug; 16(8):934-40. PubMed ID: 8696956 [TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver. Mensenkamp AR; Jong MC; van Goor H; van Luyn MJ; Bloks V; Havinga R; Voshol PJ; Hofker MH; van Dijk KW; Havekes LM; Kuipers F J Biol Chem; 1999 Dec; 274(50):35711-8. PubMed ID: 10585451 [TBL] [Abstract][Full Text] [Related]
4. Hepatic lipid accumulation, altered very low density lipoprotein formation and apolipoprotein E deposition in apolipoprotein E3-Leiden transgenic mice. Mensenkamp AR; van Luyn MJ; van Goor H; Bloks V; Apostel F; Greeve J; Hofker MH; Jong MC; van Vlijmen BJ; Havekes LM; Kuipers F J Hepatol; 2000 Aug; 33(2):189-98. PubMed ID: 10952236 [TBL] [Abstract][Full Text] [Related]
5. Mice expressing only the mutant APOE3Leiden gene show impaired VLDL secretion. Mensenkamp AR; Teusink B; Baller JF; Wolters H; Havinga R; van Dijk KW; Havekes LM; Kuipers F Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1366-72. PubMed ID: 11498467 [TBL] [Abstract][Full Text] [Related]
6. Dietary sphingolipids lower plasma cholesterol and triacylglycerol and prevent liver steatosis in APOE*3Leiden mice. Duivenvoorden I; Voshol PJ; Rensen PC; van Duyvenvoorde W; Romijn JA; Emeis JJ; Havekes LM; Nieuwenhuizen WF Am J Clin Nutr; 2006 Aug; 84(2):312-21. PubMed ID: 16895877 [TBL] [Abstract][Full Text] [Related]
7. Rosuvastatin reduces plasma lipids by inhibiting VLDL production and enhancing hepatobiliary lipid excretion in ApoE*3-leiden mice. Delsing DJ; Post SM; Groenendijk M; Solaas K; van der Boom H; van Duyvenvoorde W; de Wit EC; Bloks VW; Kuipers F; Havekes LM; Princen HM J Cardiovasc Pharmacol; 2005 Jan; 45(1):53-60. PubMed ID: 15613980 [TBL] [Abstract][Full Text] [Related]
8. Dietary plant stanol esters reduce VLDL cholesterol secretion and bile saturation in apolipoprotein E*3-Leiden transgenic mice. Volger OL; van der Boom H; de Wit EC; van Duyvenvoorde W; Hornstra G; Plat J; Havekes LM; Mensink RP; Princen HM Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):1046-52. PubMed ID: 11397718 [TBL] [Abstract][Full Text] [Related]
9. Influence of plasma free fatty acids on lipoprotein synthesis and diabetic dyslipidemia. Julius U Exp Clin Endocrinol Diabetes; 2003 Aug; 111(5):246-50. PubMed ID: 12951628 [TBL] [Abstract][Full Text] [Related]
10. Markedly increased secretion of VLDL triglycerides induced by gene transfer of apolipoprotein E isoforms in apoE-deficient mice. Tsukamoto K; Maugeais C; Glick JM; Rader DJ J Lipid Res; 2000 Feb; 41(2):253-9. PubMed ID: 10681409 [TBL] [Abstract][Full Text] [Related]
11. Acute hepatic steatosis in mice by blocking beta-oxidation does not reduce insulin sensitivity of very-low-density lipoprotein production. Grefhorst A; Hoekstra J; Derks TG; Ouwens DM; Baller JF; Havinga R; Havekes LM; Romijn JA; Kuipers F Am J Physiol Gastrointest Liver Physiol; 2005 Sep; 289(3):G592-8. PubMed ID: 15817811 [TBL] [Abstract][Full Text] [Related]
12. Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice. van Vlijmen BJ; van 't Hof HB; Mol MJ; van der Boom H; van der Zee A; Frants RR; Hofker MH; Havekes LM J Clin Invest; 1996 Mar; 97(5):1184-92. PubMed ID: 8636429 [TBL] [Abstract][Full Text] [Related]
13. Cafestol increases serum cholesterol levels in apolipoprotein E*3-Leiden transgenic mice by suppression of bile acid synthesis. Post SM; de Roos B; Vermeulen M; Afman L; Jong MC; Dahlmans VE; Havekes LM; Stellaard F; Katan MB; Princen HM Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1551-6. PubMed ID: 10845871 [TBL] [Abstract][Full Text] [Related]
14. A fish oil diet does not reverse insulin resistance despite decreased adipose tissue TNF-alpha protein concentration in ApoE-3*Leiden mice. Muurling M; Mensink RP; Pijl H; Romijn JA; Havekes LM; Voshol PJ J Nutr; 2003 Nov; 133(11):3350-5. PubMed ID: 14608043 [TBL] [Abstract][Full Text] [Related]
15. Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background impairs very-low-density lipoprotein production. Post SM; Groenendijk M; Solaas K; Rensen PC; Princen HM Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):768-74. PubMed ID: 14962946 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis. Huang Y; Ji ZS; Brecht WJ; Rall SC; Taylor JM; Mahley RW Arterioscler Thromb Vasc Biol; 1999 Dec; 19(12):2952-9. PubMed ID: 10591675 [TBL] [Abstract][Full Text] [Related]
18. Plasma lipoproteins and regulation of hepatic metabolism of fatty acids in altered thyroid states. Heimberg M; Olubadewo JO; Wilcox HG Endocr Rev; 1985; 6(4):590-607. PubMed ID: 3908084 [TBL] [Abstract][Full Text] [Related]
19. Reversal of hypercholesterolemia in apolipoprotein E2 and apolipoprotein E3-Leiden transgenic mice by adenovirus-mediated gene transfer of the VLDL receptor. van Dijk KW; van Vlijmen BJ; van der Zee A; van't Hof B; van der Boom H; Kobayashi K; Chan L; Havekes LM; Hofker MH Arterioscler Thromb Vasc Biol; 1998 Jan; 18(1):7-12. PubMed ID: 9445249 [TBL] [Abstract][Full Text] [Related]
20. Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia. Huang Y; Liu XQ; Rall SC; Taylor JM; von Eckardstein A; Assmann G; Mahley RW J Biol Chem; 1998 Oct; 273(41):26388-93. PubMed ID: 9756870 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]